Show all

Aralez Pharmaceuticals Inc. (or “Aralez”) is listed on the NASDAQ Global Market Exchange under the symbol “ARLZ” and the Toronto Stock Exchange under the symbol “ARZ”.
Aralez Pharmaceuticals Inc. became a publicly traded company on February 8, 2016, the first business day after the closing of POZEN Inc.’s acquisition of Tribute Pharmaceuticals Canada Inc (“Tribute”). POZEN Inc. (“POZEN”) was founded in 1996.
CUSIP Number: 03852X100
ISIN Number: CA03852X1006
Aralez Pharmaceuticals Inc. fiscal year end is December 31.
No, Aralez Pharmaceuticals Inc. does not offer a dividend reinvestment program. Aralez Pharmaceuticals Inc. does not expect to distribute dividends. We currently do not have any other direct means to purchase shares.
The Transfer Agent contact details are as follows:

By Telephone: 1-800-564-6253 (toll free North America) or 514-982-7555 (Int’l)
By Fax: 1-866-249-7775 (toll free North America) or 416-263-9524 (Int’l)
By Email:
By Mail: Computershare Investor Services Inc.
            8th fl, 100 University Avenue
            Toronto, ON  M5J 2Y1

Data Provided by Refinitiv. Minimum 15 minutes delayed.